Cargando…

Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis

BACKGROUND: Hyperuricemia (HUA) is becoming a global public health problem and associated with multiple diseases. OBJECTIVE: We conducted a systematic review to synthesize the pooled prevalence of HUA in mainland China and delineate its demographic, regional, and temporal trends over the past two de...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Shen, Ziyan, Zhu, Bowen, Zhang, Han, Zhang, Xiaoyan, Ding, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833047/
https://www.ncbi.nlm.nih.gov/pubmed/33475474
http://dx.doi.org/10.1080/16549716.2021.1874652
_version_ 1783641975894835200
author Li, Yang
Shen, Ziyan
Zhu, Bowen
Zhang, Han
Zhang, Xiaoyan
Ding, Xiaoqiang
author_facet Li, Yang
Shen, Ziyan
Zhu, Bowen
Zhang, Han
Zhang, Xiaoyan
Ding, Xiaoqiang
author_sort Li, Yang
collection PubMed
description BACKGROUND: Hyperuricemia (HUA) is becoming a global public health problem and associated with multiple diseases. OBJECTIVE: We conducted a systematic review to synthesize the pooled prevalence of HUA in mainland China and delineate its demographic, regional, and temporal trends over the past two decades. METHODS: Systematic literature searches of PubMed, SCOPUS, Web of Science, the China National Knowledge Infrastructure (CNKI), and the Wanfang digital database were conducted to screen studies published from 1 January 2000 to 31 August 2019, reporting the prevalence of HUA in mainland China. The search strings were (‘hyperuricemia’ OR ‘hyperuricaemia’ OR ‘uric acid’) AND (‘prevalence’ OR ‘epidemiology’) AND ‘China’. Article quality was appraised quantitatively from 11 items. Before formal meta-analysis, age-standardized prevalence was transformed. The random-effects model was applied to synthesize the pooled prevalence due to its high heterogeneity. Then we stratified the prevalence estimates by age, gender, area, nationality, and publication year for subgroup analysis. RESULTS: Totally 177 eligible studies with a whole population of 2,277,712 were included in the present meta-analysis. The pooled prevalence in mainland China was estimated at 16.4% (95% CI: 15.3%~17.6%). In studies with the onset age at 20 ~ 29 years old, males had a twice times higher HUA prevalence than females (21.5% vs. 8.9%). The prevalence of HUA was 13.7% (11.8%~15.7%) in people aged 15~ years old, 16.5% in 30~ (14.8%~18.4%), 17.9% in 40~ (16.4%~19.5%), 19.4% in 50~ (17.8%~21.0%), 20.5% in 60~ (18.8%~22.3%), and 24.9% in over 70 (22.9%~27.1%). Stratified by regions, southern (25.5%) and southwestern (21.2%) China shared the highest prevalence, and the lowest prevalence was observed in the northwest (12.6%). From 2001 to 2017, the prevalence estimates of HUA steadily climbed from 8.5% to 18.4% with minor fluctuations. Multiple regression revealed that HUA prevalence was positively correlated to the larger sample size, area, advanced onset age, and published year. CONCLUSIONS: The last two decades witnessed the rapid growth prevalence of HUA in China. Early screening and personalized health education for HUA need to be given enough attention.
format Online
Article
Text
id pubmed-7833047
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-78330472021-02-02 Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis Li, Yang Shen, Ziyan Zhu, Bowen Zhang, Han Zhang, Xiaoyan Ding, Xiaoqiang Glob Health Action Review Article BACKGROUND: Hyperuricemia (HUA) is becoming a global public health problem and associated with multiple diseases. OBJECTIVE: We conducted a systematic review to synthesize the pooled prevalence of HUA in mainland China and delineate its demographic, regional, and temporal trends over the past two decades. METHODS: Systematic literature searches of PubMed, SCOPUS, Web of Science, the China National Knowledge Infrastructure (CNKI), and the Wanfang digital database were conducted to screen studies published from 1 January 2000 to 31 August 2019, reporting the prevalence of HUA in mainland China. The search strings were (‘hyperuricemia’ OR ‘hyperuricaemia’ OR ‘uric acid’) AND (‘prevalence’ OR ‘epidemiology’) AND ‘China’. Article quality was appraised quantitatively from 11 items. Before formal meta-analysis, age-standardized prevalence was transformed. The random-effects model was applied to synthesize the pooled prevalence due to its high heterogeneity. Then we stratified the prevalence estimates by age, gender, area, nationality, and publication year for subgroup analysis. RESULTS: Totally 177 eligible studies with a whole population of 2,277,712 were included in the present meta-analysis. The pooled prevalence in mainland China was estimated at 16.4% (95% CI: 15.3%~17.6%). In studies with the onset age at 20 ~ 29 years old, males had a twice times higher HUA prevalence than females (21.5% vs. 8.9%). The prevalence of HUA was 13.7% (11.8%~15.7%) in people aged 15~ years old, 16.5% in 30~ (14.8%~18.4%), 17.9% in 40~ (16.4%~19.5%), 19.4% in 50~ (17.8%~21.0%), 20.5% in 60~ (18.8%~22.3%), and 24.9% in over 70 (22.9%~27.1%). Stratified by regions, southern (25.5%) and southwestern (21.2%) China shared the highest prevalence, and the lowest prevalence was observed in the northwest (12.6%). From 2001 to 2017, the prevalence estimates of HUA steadily climbed from 8.5% to 18.4% with minor fluctuations. Multiple regression revealed that HUA prevalence was positively correlated to the larger sample size, area, advanced onset age, and published year. CONCLUSIONS: The last two decades witnessed the rapid growth prevalence of HUA in China. Early screening and personalized health education for HUA need to be given enough attention. Taylor & Francis 2021-01-21 /pmc/articles/PMC7833047/ /pubmed/33475474 http://dx.doi.org/10.1080/16549716.2021.1874652 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Li, Yang
Shen, Ziyan
Zhu, Bowen
Zhang, Han
Zhang, Xiaoyan
Ding, Xiaoqiang
Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis
title Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis
title_full Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis
title_fullStr Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis
title_full_unstemmed Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis
title_short Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis
title_sort demographic, regional and temporal trends of hyperuricemia epidemics in mainland china from 2000 to 2019: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833047/
https://www.ncbi.nlm.nih.gov/pubmed/33475474
http://dx.doi.org/10.1080/16549716.2021.1874652
work_keys_str_mv AT liyang demographicregionalandtemporaltrendsofhyperuricemiaepidemicsinmainlandchinafrom2000to2019asystematicreviewandmetaanalysis
AT shenziyan demographicregionalandtemporaltrendsofhyperuricemiaepidemicsinmainlandchinafrom2000to2019asystematicreviewandmetaanalysis
AT zhubowen demographicregionalandtemporaltrendsofhyperuricemiaepidemicsinmainlandchinafrom2000to2019asystematicreviewandmetaanalysis
AT zhanghan demographicregionalandtemporaltrendsofhyperuricemiaepidemicsinmainlandchinafrom2000to2019asystematicreviewandmetaanalysis
AT zhangxiaoyan demographicregionalandtemporaltrendsofhyperuricemiaepidemicsinmainlandchinafrom2000to2019asystematicreviewandmetaanalysis
AT dingxiaoqiang demographicregionalandtemporaltrendsofhyperuricemiaepidemicsinmainlandchinafrom2000to2019asystematicreviewandmetaanalysis